Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | -1.75% | +2.75% | +29.48% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 166M | Capitalization | 132M |
---|---|---|---|---|---|
Net income 2024 * | -146M | Net income 2025 * | -138M | EV / Sales 2024 * | 0.91 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
-0.91
x | P/E ratio 2025 * |
-1.36
x | Employees | 325 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.64% |
Latest transcript on Karyopharm Therapeutics Inc.
1 day | -1.75% | ||
1 week | +2.75% | ||
Current month | +8.74% | ||
1 month | -4.27% | ||
3 months | -7.44% | ||
6 months | +51.72% | ||
Current year | +29.48% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 19-02-24 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 13-10-02 |
Barry Greene
BRD | Director/Board Member | 60 | 12-12-31 |
Director/Board Member | 59 | 13-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +9.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1.12 | -1.75% | 1,222,720 |
24-05-20 | 1.14 | -0.87% | 1,234,041 |
24-05-17 | 1.15 | +1.32% | 1,559,980 |
24-05-16 | 1.135 | +0.44% | 1,958,377 |
24-05-15 | 1.13 | +3.67% | 1,845,570 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.48% | 134M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- KPTI Stock